New York A11048 regulates the use of artificial intelligence by insurers and clinical peer reviewers in utilization review and establishes additional.

New York A11048 amends the insurance law and public health law to regulate the use of artificial intelligence by insurers and clinical peer reviewers in utilization review. It mandates that adverse determinations be made by clinical peer reviewers, not solely by artificial intelligence. Insurers must submit their artificial intelligence algorithms and training data sets to the superintendent, ensuring they minimize bias and adhere to evidence-based clinical guidelines.

New York A11048 regulates the use of artificial intelligence by insurers and clinical peer reviewers in utilization review and establishes additional.

New York A11048 amends the insurance law and public health law to regulate the use of artificial intelligence by insurers and clinical peer reviewers in utilization review. It mandates that adverse determinations be made by clinical peer reviewers, not solely by artificial intelligence. Insurers must submit their artificial intelligence algorithms and training data sets to the superintendent, ensuring they minimize bias and adhere to evidence-based clinical guidelines.